Smith & Nephew plc (NYSE:SNN) Short Interest Update

Smith & Nephew plc (NYSE:SNN - Get Free Report) was the target of a large decline in short interest in January. As of January 15th, there was short interest totalling 2,140,000 shares, a decline of 23.3% from the December 31st total of 2,790,000 shares. Approximately 0.5% of the shares of the company are sold short. Based on an average daily volume of 904,700 shares, the days-to-cover ratio is currently 2.4 days.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the stock. Principal Securities Inc. lifted its stake in shares of Smith & Nephew by 87.6% in the fourth quarter. Principal Securities Inc. now owns 1,480 shares of the medical equipment provider's stock worth $36,000 after acquiring an additional 691 shares during the period. R Squared Ltd acquired a new position in Smith & Nephew in the fourth quarter valued at approximately $41,000. Hara Capital LLC boosted its holdings in shares of Smith & Nephew by 391.4% during the 4th quarter. Hara Capital LLC now owns 2,457 shares of the medical equipment provider's stock worth $60,000 after buying an additional 1,957 shares in the last quarter. GAMMA Investing LLC grew its position in shares of Smith & Nephew by 160.0% during the 3rd quarter. GAMMA Investing LLC now owns 2,257 shares of the medical equipment provider's stock worth $70,000 after buying an additional 1,389 shares during the period. Finally, Allspring Global Investments Holdings LLC grew its position in shares of Smith & Nephew by 74.4% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 3,025 shares of the medical equipment provider's stock worth $94,000 after buying an additional 1,290 shares during the period. 25.64% of the stock is owned by institutional investors.

Smith & Nephew Stock Down 0.0 %

Shares of Smith & Nephew stock traded down $0.01 on Monday, hitting $25.37. The stock had a trading volume of 260,092 shares, compared to its average volume of 829,148. The stock has a 50 day moving average of $25.05 and a 200 day moving average of $27.64. Smith & Nephew has a twelve month low of $23.65 and a twelve month high of $31.72. The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.11 and a current ratio of 2.51.

Wall Street Analyst Weigh In

A number of analysts have recently weighed in on the company. Berenberg Bank downgraded Smith & Nephew from a "buy" rating to a "hold" rating in a research report on Wednesday, November 6th. Deutsche Bank Aktiengesellschaft cut shares of Smith & Nephew from a "buy" rating to a "hold" rating in a research report on Friday, November 1st. Finally, StockNews.com lowered shares of Smith & Nephew from a "strong-buy" rating to a "buy" rating in a report on Tuesday, November 12th.

Smith & Nephew Company Profile

Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT.